A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease
Year: 2021
Type: review
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-215065
Authors: Sanchari Mukhopadhyay, Debanjan Banerjee
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3191310544